ClinicalTrials.gg
CompletedNCT04864925Updated Jan 18, 2022

Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products

A Phase 3 interventional study of Colgate Total Clean Mint and Tom's Botanically Bright Peppermint in Covid19, sponsored by Colgate Palmolive. Completed at 1 site in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2022-01-18.

Sponsored by Colgate Palmolive · Phase 3, Interventional, and Prevention

From the registry’s dates

  • Primary completion was Aug 2021, 5 years 2 months ago, and no results have been posted to the registry.
  • Registered 3 months after the study started (first participant enrolled Dec 2020, registered Apr 2021).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 1,859 studies in COVID-19 with a site in United States — 120 open to participants now, 210 under way, 16 of them phase 3. COVID-19 · United States.

Enrollment
852nd of 1,321
46 · median 91
Started
2020
with 817 others
Phase 3
174 of 1,859
11 open now
Registered
1,109th of 1,859
by date

Among the 1,859 studies in COVID-19 with a site in United States, this one is the 852nd largest by enrollment of the 1,321 interventional ones that give a count, is one of 818 that started in 2020, is one of 174 in phase 3, and was the 1,109th registered.

COVID-19

7,994 studies on the registry are indexed under COVID-19; 467 are open to participants now.

Browse COVID-19 studies →

Open to participants now

120 of the 1,859 studies in COVID-19 with a site in United States are open now. Recruiting first, the newest first:

115 more — sign in →

All 120 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 356 COVID-19 studies recruiting now, 206 (58%) set no upper age limit and 83 (23%) stop at 75 or younger; 91 take children under 18; 135 take healthy volunteers.

This study: 18 Years to 64 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,859 studies in COVID-19 with a site in United States, or all of them as a file.
02

Study summary

SARS COVID 2 has caused a pandemic of proportions unparalleled in the past 100 years. The virus has an uncanny ability for transmission and as such has been difficult to control. The spread of the virus has affected everything from education, business, politics and survival. While the investigators have learned a great deal in the last 9 months they still face an uncertain day to day existence. Health care workers are particularly vulnerable to transmission of this virus because of their close contact with patients. Moreover, dentists are particularly vulnerable because the virus is spread via aerosols which are generated quite easily in the dental office putting dentists and their associates at risk. The oral cavity appears to be a likely domain for viral carriage particularly since both taste and smell are hallmark effects of the virus. With these issues at hand it will be of great advantage to have a simple routine oral hygiene method in the effort to reduce the oral viral load. There is some reason to expect that oral hygiene procedures with known anti-microbial effects could have some use in our efforts to reduce or control the oral viral load. With this issue in mind investigators feel that stannous fluoride could modify the virus in such a manner as to effectively reduce the oral viral load.

Read the detailed description

Study will measure reduction of SARS-CoV-2 levels in the oral cavity after brushing for up to an hour. Subject sampling will occur at baseline, 15 min, 30 min, and 60 min

03

Conditions studied

  • Covid19

Browse trials for

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Enrolled subjects between the ages of 18-64 and have tested positive for Covid19.

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
46 participants (actual)

Study arms

  • Experimental
    Colgate Total Clean Mint

    Brush with toothpaste for a minimum of 2 minutes

    Drug: Colgate Total Clean Mint

  • Active comparator
    Tom's Botanically Bright Peppermint

    Brush with toothpaste for a minimum of 2 minutes

    Drug: Tom's Botanically Bright Peppermint

Interventions

06

What researchers measure

Primary outcomes

  1. Primary outcome based on reductions of viral titers in the oral cavity as determined by qRT-PCR

    Primary outcome based on reductions of viral titers in the oral cavity as determined by qRT-PCR

    Time frame: Baseline

  2. Primary outcome based on reductions of viral titers in the oral cavity as determined by qRT-PCR

    Primary outcome based on reductions of viral titers in the oral cavity as determined by qRT-PCR

    Time frame: 30 minutes after brushing

  3. Primary outcome based on reductions of viral titers in the oral cavity as determined by qRT-PCR

    Primary outcome based on reductions of viral titers in the oral cavity as determined by qRT-PCR

    Time frame: 60 minutes after brushing

07

Study locations

1 site
  • Rutgers University Hospital
    Newark, New Jersey 07103, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2020 to primary completion in Aug 2021, 7 months.

Of 168 industry-sponsored phase 3 interventional studies under COVID-19, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 16. This study's 7 months is below that.

Counting every sponsor, half of 453 studies reached it within 9 months; a quarter within 4 and three quarters within 17.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2021
First posted
Apr 29, 2021
StartActual
Dec 28, 2020
Primary completionActual
Aug 25, 2021
CompletionActual
Aug 25, 2021
Last update
Jan 18, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04864925
Lead sponsor
Colgate Palmolive
Responsible party
Sponsor
First posted
Apr 29, 2021
Start date
Dec 28, 2020
Primary completion
Aug 25, 2021
Completion
Aug 25, 2021
Last update
Jan 18, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Toothpaste

Start the discussion